rs200411253
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039141.3(TRIOBP):c.6803G>A(p.Gly2268Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,611,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001039141.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIOBP | ENST00000644935.1 | c.6803G>A | p.Gly2268Asp | missense_variant | Exon 21 of 24 | NM_001039141.3 | ENSP00000496394.1 | |||
TRIOBP | ENST00000403663.6 | c.1664G>A | p.Gly555Asp | missense_variant | Exon 11 of 14 | 1 | ENSP00000386026.2 | |||
TRIOBP | ENST00000344404.10 | n.*6286G>A | non_coding_transcript_exon_variant | Exon 19 of 22 | 2 | ENSP00000340312.6 | ||||
TRIOBP | ENST00000344404.10 | n.*6286G>A | 3_prime_UTR_variant | Exon 19 of 22 | 2 | ENSP00000340312.6 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152266Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000194 AC: 47AN: 242520Hom.: 0 AF XY: 0.000189 AC XY: 25AN XY: 132566
GnomAD4 exome AF: 0.000141 AC: 205AN: 1459054Hom.: 0 Cov.: 33 AF XY: 0.000142 AC XY: 103AN XY: 725790
GnomAD4 genome AF: 0.000131 AC: 20AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74390
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Gly2268Asp variant in TRIOBP has not been reported in individuals with heari ng loss. Data from large population studies is insufficient to assess the freque ncy of this variant. This variant has been reported in the dbSNP without any pop ulation information (dbSNP rs200411253). Computational analyses (biochemical ami no acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, additional information is needed to fully assess the clinical significance of the Gly2268A sp variant. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Hearing impairment Uncertain:1
PM2_Supporting, BP4_Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at